PURE Bioscience Reports Q2 EPS of $(0.07)

PURE Bioscience PUREtoday reported product revenues for the fiscal second quarter ended January 31, 2011 of $58,400, compared with product revenues of $327,000 in the same quarter of the prior fiscal year.

The Company reported a net loss of $2,479,600 or $(0.07) per share for the current quarter, compared with a net loss of $1,766,200 or $(0.05) per share in the second fiscal quarter last year. Also during the second quarter of fiscal year 2011, the Company recorded licensing revenue of $10,000.